Ohr Pharmaceutical (NASDAQ: OHRP) is down 3.8% early on stronger-than-normal volume following a negative post from Richard Pearson ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE